Chances for licensing-in of new drugs from abroad more difficult.

Published: 2000-10-19 09:21:00

Updated: 2000-10-19 09:21:00

As most of foreign multinational drug corporations already established their business presence in Korea, it is far less chances for domestic drug companies to make a licensing business tie-up with foreign research companies.

Having realized the importance of pipeline products in their business...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK